Insulin Resistance Treatment in Tampa, FL

'Standard fasting glucose and HbA1c tests catch overt prediabetes and diabetes but often miss early insulin resistance. At AgeRejuvenation, we add fasting insulin, C-peptide, and HOMA-IR calculations to the panel, which reveal insulin dysregulation before glucose levels are high enough to trigger a standard diagnosis. We also assess inflammatory markers, thyroid function, and lipid subfractions because these interact directly with insulin signaling.'

'Yes, in many patients, especially early-stage insulin resistance. Consistent aerobic exercise, reduced processed carbohydrate intake, adequate protein, stress management, and improved sleep independently improve insulin sensitivity. However, for patients with significant weight to lose, hormonal imbalances, or prediabetes-range glucose, medical therapies like GLP-1 medications dramatically accelerate improvement and reduce the timeline to meaningful change.'

'Insulin resistance is the underlying dysfunction; prediabetes is a blood glucose measurement indicating that dysfunction has progressed significantly. You can be insulin resistant for years with blood glucose still in the normal range. When glucose climbs to 100-125 mg/dL fasting (or HbA1c 5.7-6.4%), the clinical label becomes prediabetes. Both conditions benefit from the same interventions; identifying insulin resistance before it reaches prediabetes gives you more time and more options.'

'Metabolic lab testing coverage varies by plan. GLP-1 medications like semaglutide are increasingly covered for type 2 diabetes diagnoses but coverage for weight management varies significantly by insurer. Our team can provide itemized cost information and help you understand what your plan may cover. Financing options are also available through AgeRejuvenation.'

'Standard primary care typically monitors fasting glucose and HbA1c annually and may recommend dietary changes. AgeRejuvenation goes deeper: we test fasting insulin, assess hormonal contributors (testosterone, thyroid, cortisol), integrate advanced diagnostics with medical weight loss and GLP-1 therapy, and provide ongoing monitoring and protocol adjustments. We address insulin resistance as a systemic metabolic and hormonal problem rather than a single lab value to watch.'